Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 231,097,430 papers from all fields of science
Search
Sign In
Create Free Account
SNHG7 gene
Known as:
SNHG7
, MGC16037
, NCRNA00061
Expand
National Institutes of Health
Create Alert
Alert
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
2020
2020
Long Noncoding RNA SNHG7, a Molecular Sponge for microRNA-485, Promotes the Aggressive Behavior of Cervical Cancer by Regulating PAK4
Fei Wu
,
Yujie Sui
,
Yinhuai Wang
,
Tianmin Xu
,
L. Fan
,
He Zhu
OncoTargets and Therapy
2020
Corpus ID: 210972944
Purpose A long noncoding RNA called small nucleolar RNA host gene 7 (SNHG7) is known to be a key regulator of biological…
Expand
2020
2020
Downregulation of lncRNA SNHG7 inhibits proliferation and invasion of nasopharyngeal carcinoma cells through repressing ROCK1.
L. Wang
,
XU T.
,
+5 authors
Y. Jiang
European Review for Medical and Pharmacological…
2020
Corpus ID: 198998863
OBJECTIVE Recent studies have revealed the important role of long noncoding RNAs (lncRNAs) in the progression of tumorigenesis…
Expand
2020
2020
Long non-coding RNA SNHG7 promotes malignant melanoma progression through negative modulation of miR-9.
Wendi Wang
,
Guangjing Liu
,
Man Liu
,
Xiaobing Li
Histology and Histopathology
2020
Corpus ID: 218504248
Long non-coding small nucleolar RNA host gene 7 (lncRNA SNHG7) was verified to act as an onco-gene in human cancers. Nevertheless…
Expand
2016
2016
Long non-coding RNA SNHG 7 promotes proliferation and self-renewal of glioblastoma cells
Jiyong Leng
,
W. Xiong
,
Xinmin Wang
,
Kezhen Wang
,
Hongzhu Lv
,
Peiyu Cong
2016
Corpus ID: 43947856
Glioblastoma multiform (GBM) is the most lethal brain tumor due to the aggressive proliferation and resistance to radioand…
Expand
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE